Zyversa Therapeutics Inc
(ZVSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,531 | 3,138 | 5,902 | 329 | N/A |
| Other current assets | 0 | 0 | 235 | 376 | 0 |
| TOTAL | $1,716 | $3,353 | $6,363 | $812 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 0 | 7 | 17 | 28 | N/A |
| Intangibles | 18,648 | 18,648 | 111,981 | 0 | 0 |
| Other Non-Current Assets | 236 | 106 | 145 | 287 | 0 |
| TOTAL | $18,884 | $18,761 | $112,144 | $314 | $N/A |
| Total Assets | $20,599 | $22,114 | $118,506 | $1,126 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,337 | 8,432 | 6,026 | 2,000 | 0 |
| Accrued Expenses | 1,894 | 1,755 | 2,054 | 1,914 | N/A |
| Other current liabilities | N/A | N/A | N/A | 561 | N/A |
| TOTAL | $11,231 | $10,195 | $8,188 | $13,626 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 331 | 331 | 0 |
| TOTAL | $852 | $845 | $10,655 | $331 | $N/A |
| Total Liabilities | $12,083 | $11,040 | $18,843 | $13,958 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,568 | 759 | N/A | N/A | N/A |
| Retained earnings | -112,633 | -103,219 | -4,921 | -52,897 | N/A |
| Other shareholders' equity | -7 | -7 | 0 | 0 | 0 |
| TOTAL | $8,516 | $11,075 | $99,663 | $-12,832 | $N/A |
| Total Liabilities And Equity | $20,599 | $22,114 | $118,506 | $1,126 | $0 |